AGC Biologics Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility
13 sept. 2021 19h57 HE
|
AGC Biologics
Heidelberg, Germany, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced expansion plans...
Precise Biometrics Acquires Remaining Shares in Loqware Sweden AB
13 oct. 2005 04h33 HE
|
Precise Biometrics AB
LUND, Sweden, Oct. 13, 2005 (PRIMEZONE) -- Precise Biometrics AB (publ), which develops and markets world-leading, user-friendly biometric security solutions based on fingerprint recognition and...
Pharming to Present at UBS Global Life Sciences Conference
20 sept. 2005 01h38 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Sept. 20, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company will present at the...
Pharming's Recombinant Human Fibrinogen Selected for U.S. Army Project
31 août 2005 02h07 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 31, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHARM.AS) announced today that its recombinant human fibrinogen...
Biovitrum Acquires the Pharmaceutical Company Arexis
22 août 2005 03h15 HE
|
Biovitrum
STOCKHOLM, Sweden, Aug. 22, 2005 (PRIMEZONE) -- Biovitrum expands the project portfolio with projects in clinical phase, both I and II, together with additional preclinical projects within its...
Galapagos Announces Half Year 2005 Results
12 août 2005 02h24 HE
|
Galapagos Genomics
Mechelen, Belgium, Aug. 12, 2005 (PRIMEZONE) -- Galapagos:
- Financials on target for 2005 increased annual revenues and
cash burn of around 7 million euro
- Initial public offering...
SSIMED's EMR To Utilize Cerner Multum Drug, Herbal and Nutraceutical Database
26 juil. 2005 01h33 HE
|
SSIMED Corporation
WINDSOR, Conn., July 26, 2005 (PRIMEZONE) -- SSIMED Corporation, provider of medical practice management software and services, is pleased to announce that it has chosen Cerner Multum(TM) content and...
Q-Med Acquires Ixion's Entire Oxalate Project
27 juin 2005 04h35 HE
|
Q-Med
UPPSALA, Sweden, June 27, 2005 (PRIMEZONE) -- Through a series of internal transactions Q-Med will become the sole owner of the product development of pharmaceuticals preventing kidney stones. The...
Keryx Biopharmaceuticals to Present at Banc of America Securities Annual Health Care Conference
17 mai 2005 08h29 HE
|
Keryx Biopharmaceuticals, Inc.
NEW YORK, May 17, 2005 (PRIMEZONE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), announced today that Michael S. Weiss, Chairman and Chief Executive Officer, will present an overview of the...
MorphoSys Provides Update on MOR102 Program in Psoriasis
28 avr. 2005 01h37 HE
|
MorphoSys AG
MARTINSRIED, Germany, April 28, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (MOR; Prime Standard Segment, TecDAX) today provided an update on its MOR102 antibody program for chronic inflammatory...